Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Therapeutic Target(s) for Psoriatic Disease
Vishal Thakur, Rahul Mahajan
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 24

Showing 24 citing articles:

Inflammation and Psoriasis: A Comprehensive Review
Alessandra-Mădălina Man, Meda Sandra Orăsan, Oana-Alina Hoteiuc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16095-16095
Open Access | Times Cited: 36
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
Lisha Li, Jiaye Lu, Jun Liu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 15
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review
Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 279-295
Closed Access | Times Cited: 18
Challenges in Psoriasis Research: A Systematic Review of Preclinical Models
Ana Ubago-Rodríguez, Maria I. Quiñones‐Vico, Manuel Sánchez‐Díaz, et al.
Dermatology (2024) Vol. 240, Iss. 4, pp. 620-652
Closed Access | Times Cited: 4
Outline of Therapeutic Potential of Different Plants Reported Against Psoriasis via In Vitro, Pre‐Clinical or Clinical Studies
Pawan Gupta, Sudhakar Kalvatala, Abhinav Joseph, et al.
Phytotherapy Research (2025)
Closed Access
Integrating Transcriptomics and Network Pharmacology to Reveal the Effect and Mechanism of Bai-Jie-Jing-Xie Ointment on Improving Skin Inflammation of Psoriasis
Yuping Lin, Xiujuan Zhao, Ziqing Yang, et al.
Journal of Ethnopharmacology (2025), pp. 119680-119680
Closed Access
Current and emerging prospects in the psoriatic treatment
Rutuja Vilas Nikam, M Gowtham, Pratiksha Sanjay More, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110331-110331
Closed Access | Times Cited: 10
Aberrant promoter methylation of Wnt inhibitory factor-1 gene is a potential target for treating psoriasis
Liu Liu, Yaqiong Zhou, Dan Luo, et al.
Clinical Immunology (2023) Vol. 250, pp. 109294-109294
Closed Access | Times Cited: 9
Histone modification in psoriasis: Molecular mechanisms and potential therapeutic targets
Ruifeng Liu, Luyao Zhang, Kaiming Zhang
Experimental Dermatology (2024) Vol. 33, Iss. 8
Closed Access | Times Cited: 3
NEK2 overexpression aggravates IL-22-induced keratinocyte proliferation and cytokine level increases and IMQ-induced psoriasis-like dermatitis
Youhua Peng, Yujin Zhang, Meijunzi Luo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 8, pp. 119525-119525
Closed Access | Times Cited: 7
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
Laura Mateu Arrom, L. Puig
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 363-379
Closed Access | Times Cited: 2
Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway
Jun Ma, Ji Chen, Yanhong Sun, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 2
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients
Peter Foley, Kurt Gebauer, John Sullivan, et al.
Australasian Journal of Dermatology (2023) Vol. 64, Iss. 4, pp. 476-487
Open Access | Times Cited: 5
Single-cell technologies in psoriasis
Niannian Cui, Xiaoqing Xu, Fusheng Zhou
Clinical Immunology (2024) Vol. 264, pp. 110242-110242
Open Access | Times Cited: 1
Tissue gene expression profiles and communication networks inform candidate blood biomarker identification in psoriasis and atopic dermatitis
Jamie Soul, Enar Carlsson, Sigrun R. Hofmann, et al.
Clinical Immunology (2024) Vol. 265, pp. 110283-110283
Open Access | Times Cited: 1
An overview of Skp2: a promising new therapeutic target of psoriasis
Yashika Tomar, Moushumi Baidya, Jay Chadokiya, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 689-700
Closed Access | Times Cited: 1

Salvador Pedraza, Arturo Armiñana, Celia Montón-Gómez, et al.
ANALES RANM (2023) Vol. 140, Iss. 140(02)
Open Access | Times Cited: 3
Pso-Reg: a web registry for psoriasis in real life
Emanuele Trovato, Alessandra Cartocci, Laura Calabrese, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 3
Closed Access | Times Cited: 2
Immunoproteasome inhibition attenuates experimental psoriasis
Marta del Rio Oliva, Mark Mellett, Michael Basler
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Green preparation and evaluation of the anti‐psoriatic activity of vesicular elastic nanocarriers of kojic acid from Aspergillus oryzae N12: Repurposing of a dermo‐cosmetic lead
Ashaimaa Y. Moussa, Haidy Abbas, Mariam Zewail, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access
The Epidemiology, Etiology, and Therapeutic Approaches of Psoriasis: A Review Article
Maytham Adil, Ali A. Al-fahham, Nabaa Basim Alhusseini
INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH (2024) Vol. 03, Iss. 08
Open Access
Molecular treatment trajectories within psoriatic T lymphocytes: a mini review
Martyna Kuczyńska, Magdalena Gabig‐Cimińska, Marta Moskot
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Gene Ontology Analysis Highlights Biological Processes Influencing Responsiveness to Biological Therapy in Psoriasis
Martina Krušič, Gregor Jezernik, Uroš Potočnik
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2024-2024
Open Access | Times Cited: 1
Oral small molecules: new therapeutic targets in psoriasis
Luisa Martos‐Cabrera, R. Sampedro‐Ruiz, Mar Llamas‐Velasco, et al.
ANALES RANM (2023) Vol. 140, Iss. 140(02), pp. 142-152
Open Access
Page 1

Scroll to top